Opinion: Burdensome Medicare GLP-1 program may keep patients from accessing $50 per month weight loss drugs

Medicare’s new weight loss drug program “risks creating barriers at precisely the moment when confidence in broader GLP‑1 coverage is most needed,” writes Jeffrey Millstein.